ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 145 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $62 | -92.1% | 20,828 | -87.9% | 0.00% | – |
| Q1 2024 | $780 | +13.2% | 172,358 | +42.8% | 0.00% | – |
| Q4 2023 | $689 | +610.3% | 120,657 | +474.9% | 0.00% | – |
| Q3 2023 | $97 | -97.1% | 20,986 | -96.0% | 0.00% | -100.0% |
| Q2 2023 | $3,397 | -13.5% | 525,964 | +1.0% | 0.00% | 0.0% |
| Q1 2023 | $3,925 | +22.2% | 520,521 | +64.2% | 0.00% | +100.0% |
| Q4 2022 | $3,211 | -99.9% | 317,028 | +34.1% | 0.00% | -66.7% |
| Q3 2022 | $2,338,000 | -9.0% | 236,398 | -2.0% | 0.00% | +50.0% |
| Q2 2022 | $2,569,000 | +6.2% | 241,228 | -2.8% | 0.00% | 0.0% |
| Q1 2022 | $2,418,000 | – | 248,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |